The effect of bovine IFN-alpha on the immune response in guinea pigs vaccinated with DNA vaccine of foot-and-mouth disease virus.

In this study, we constructed recombinant plasmid pcDNA3.1/P12X3C3D including P1, 2A, 3C, 3D and part of 2B gene of FMDV and pcDNA3.1/IFN containing the gene encoding bovine IFN-alpha. We inoculated the DNA vaccine pcDNA3.1/P12X3C3D with or without pcDNA3.1/IFN to evaluate the efficiency of this DNA vaccine and the immunogenicity of DNA vaccine enhanced by the co-delivery with pcDNA3.1/IFN. After two times of vaccination with DNA vaccine, all of guinea pigs were challenged with 103 ID50 FMDV type O. Anti-FMDV antibody levels were detected by ELISA and T lymphocyte proliferation response was tested by MTT assay. The result shows that guinea pigs inoculated by pcDNA3.1/P12X3C3D alone or with pcDNA3.1/IFN generated specific antibodies and induced an FMDV-specific T lymphocyte proliferation response. FMDV challenge tests showed that one in four guinea pigs immunized by pcDNA3.1/P12X3C3D with pcDNA3.1/IFN was protected from the FMDV serotype O infection. This result indicated that the efficiency of the DNA vaccine was enhanced by co-delivery with pcDNA3.1/IFN. However, the protection rate was considerably lower than that immunized with conventional FMD vaccine.

[1]  J. W. Wilesmith,et al.  Descriptive epidemiology of the 2001 foot-and-mouth disease epidemic in Great Britain: the first five months , 2001, Veterinary Record.

[2]  M. Ramanathan,et al.  Induction of potent Th1-type immune responses from a novel DNA vaccine for West Nile virus New York isolate (WNV-NY1999). , 2001, The Journal of infectious diseases.

[3]  M. Collins,et al.  Cytokine adjuvancy of BVDV DNA vaccine enhances both humoral and cellular immune responses in mice. , 2001, Vaccine.

[4]  R. Parkhouse,et al.  Induction of a protective response in swine vaccinated with DNA encoding foot-and-mouth disease virus empty capsid proteins and the 3D RNA polymerase. , 2001, The Journal of general virology.

[5]  M. Grubman,et al.  Inhibition of L-Deleted Foot-and-Mouth Disease Virus Replication by Alpha/Beta Interferon Involves Double-Stranded RNA-Dependent Protein Kinase , 2001, Journal of Virology.

[6]  R. Kitching,et al.  Outbreak of foot-and-mouth disease virus serotype O in the UK caused by a pandemic strain. , 2001, The Veterinary record.

[7]  D. Weiner,et al.  Improving DNA Vaccines Targeting Viral Infection , 2001, Intervirology.

[8]  S. Cheng,et al.  Plasmids encoding foot-and-mouth disease virus VP1 epitopes elicited immune responses in mice and swine and protected swine against viral infection. , 2000, Virology.

[9]  S. Goodbourn,et al.  Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. , 2000, The Journal of general virology.

[10]  H. T. Sung,et al.  Epidemiological characteristics and financial costs of the 1997 foot-and-mouth disease epidemic in Taiwan , 1999, Veterinary Record.

[11]  M. Grubman,et al.  Ability of Foot-and-Mouth Disease Virus To Form Plaques in Cell Culture Is Associated with Suppression of Alpha/Beta Interferon , 1999, Journal of Virology.

[12]  P. Mason,et al.  Development of DNA vaccines for foot-and-mouth disease, evaluation of vaccines encoding replicating and non-replicating nucleic acids in swine. , 1999, Journal of biotechnology.

[13]  B. Williams,et al.  Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways. , 1999, Virology.

[14]  R. Parkhouse,et al.  Heterotypic recognition of recombinant FMDV proteins by bovine T-cells: the polymerase (P3Dpol) as an immunodominant T-cell immunogen. , 1998, Virus research.

[15]  E. Raz,et al.  Gene vaccination: plasmid DNA is more than just a blueprint. , 1998, Immunology today.

[16]  G. Belsham,et al.  Assembly of foot-and-mouth disease virus empty capsids synthesized by a vaccinia virus expression system. , 1995, The Journal of general virology.

[17]  G. Belsham,et al.  Intracellular expression and processing of foot-and-mouth disease virus capsid precursors using vaccinia virus vectors: influence of the L protease. , 1990, Virology.

[18]  G. Belsham,et al.  Specificity of enzyme-substrate interactions in foot-and-mouth disease virus polyprotein processing. , 1989, Virology.

[19]  V. Vakharia,et al.  Analysis of neutralizing antigenic sites on the surface of type A12 foot-and-mouth disease virus , 1989, Journal of virology.

[20]  H. Schaller,et al.  Nucleotide sequence and genome organization of foot-and-mouth disease virus. , 1984, Nucleic acids research.

[21]  B. Clarke,et al.  The complete nucleotide sequence of the RNA coding for the primary translation product of foot and mouth disease virus. , 1984, Nucleic acids research.

[22]  F. Brown,et al.  Biochemical identification of viruses causing the 1981 outbreaks of foot and mouth disease in the UK , 1981, Nature.

[23]  R. Ahl,et al.  Assay of bovine interferons in cultures of the porcine cell line IB-RS-2 , 1976, Infection and immunity.

[24]  R. Sellers.  Multiplication, Interferon Production and Sensitivity of Virulent and Attenuated Strains of the Virus of Foot-and-mouth Disease , 1963, Nature.

[25]  M. Ramanathan,et al.  Induction of Potent Th 1-Type Immune Responses from a Novel DNA Vaccine for West Nile Virus New York Isolate ( WNV-NY 1999 ) , 2001 .

[26]  R. Parkhouse,et al.  Serological and cellular immune responses to non-structural proteins in animals infected with FMDV. , 1998, The Veterinary quarterly.

[27]  M. Lenman.  Synthetic and structural studies of foot-and-mouth disease virus polyprotein processing , 1996 .

[28]  W. B.,et al.  Foot and mouth disease. , 2002, Research in veterinary science.